The presence and potential role of dopaminergic dysfunction remains unclear in AD, with a recent report suggesting that dopaminergic system could be linked with the pathophysiology of AD [258], whilst another showed no changes in DAT uptake in early-onset AD patients [272]. Here, SLC6A3 is linked to Alzheimer disease.